References
- 1. Kelly, J. W. Alternative Conformations of Amyloidogenic Proteins Govern Their Behavior. – Current Opinion in Structural Biology, Vol. 6, 1996, No 1, pp. 11-17.
- 2. Koo, E. H., P. T. Lansbury, J. W. Kelly. Amyloid Diseases: Abnormal Protein Aggregation in Neurodegeneration. – Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, 1999, No 18, pp. 9989-9990.
- 3. Ballard, C., S. Gauthier, A. Corbett, C. Brayne, D. Aarsland, E. Jones. Alzheimer’s Disease. – Lancet (London, England), Vol. 377, 2011, No 9770, pp. 1019-1031.
- 4. Selkoe, D. J. Alzheimer’s Disease : Genes, Proteins, and Therapy. – Physiological Reviews, Vol. 81, 2001, No 2, pp. 741-766.
- 5. Goedert, M., M. G. Spillantini. A Century of Alzheimer’s Disease. – Science, Vol. 314, 2006, No 5800, pp. 777-781.
- 6. Hardy, J., D. Selokoe. The Amyloid Hypothesis of Alzheimer ’s Disease. – Science, Vol. 297, 2002, No 5580, pp. 353-357.
- 7. Lazarov, O., M. P. Demars. All in the Family: How the Apps Regulate Neurogenesis. – Frontiers in Neuroscience, Vol. 6, 2012, No JUN, pp. 1-21.
- 8. Kamenetz, F., T. Tomita, H. Hsieh, G. Seabrook, D. Borchelt, T. Iwatsubo, S. Sisodia, R. Malinow. APP Processing and Synaptic Function. – Neuron, Vol. 37, 2003, No 6, pp. 925-937.
- 9. Vardy, E. R. L. C., A. J. Catto, N. M. Hooper. Proteolytic Mechanisms in Amyloid-β Metabolism: Therapeutic Implications for Alzheimer’s Disease. – Trends in Molecular Medicine, Vol. 11, 2005, No 10, pp. 464-472.
- 10. Beel, A. J., C. R. Sanders. Substrate Specificity of γ-Secretase and Other Intramembrane Proteases. – Cellular and Molecular Life Sciences, Vol. 65, 2008, No 9, pp. 1311-1334.
- 11. Jarrett, J. T., E. P. Berger, P. T. Lansbury. The Carboxy Terminus of the Beta Amyloid Protein is Critical for the Seeding of Amyloid Formation: Implications for the Pathogenesis of Alzheimer’s Disease. – Biochemistry, Vol. 32, 1993, No 18, pp. 4693-4697.
- 12. Harper, J. D., P. T. Lansbury. Models of Amyloid Seeding in Alzheimer’s Disease and Scrapie: Mechanistic Truths and Physiological Consequences of the Time-Dependent Solubility of Amyloid Proteins. – Annual Review of Biochemistry, Vol. 66, 1997, No 1, pp. 385-407.
- 13. Harper, J. D., C. M. Lieber, P. T. Lansbury. Atomic Force Microscopic Imaging of Seeded Fibril Formation and Fibril Branching by the Alzheimer’s Disease Amyloid-β Protein. – Chemistry & Biology, Vol. 4, 1997, No 12, pp. 951-959.
- 14. Soto, C., E. M. Castaño, B. Frangione, N. C. Inestrosa. The -Helical to -Strand Transition in the Amino-Terminal Fragment of the Amyloid -Peptide Modulates Amyloid Formation. – Journal of Biological Chemistry, Vol. 270, 1995, No 7, pp. 3063-3067.
- 15. Glabe, C. G. Structural Classification of Toxic Amyloid Oligomers. – Journal of Biological Chemistry, Vol. 283, 2008, No 44, pp. 29639-29643.
- 16. Strittmatter, W. J., A. D. Roses. Apolipoprotein E and Alzheimer Disease. – Proceedings of the National Academy of Sciences, Vol. 92, 1995, No 11, pp. 4725-4727.
- 17. Holtzman, D. M., K. R. Bales, T. Tenkova, A. M. Fagan, M. Parsadanian, L. J. Sartorius, B. Mackey, J. Olney, D. McKeel, D. Wozniak, S. M. Paul. Apolipoprotein E Isoform-Dependent Amyloid Deposition and Neuritic Degeneration in a Mouse Model of Alzheimer’s Disease. – Proceedings of the National Academy of Sciences, Vol. 97, 2000, No 6, pp. 2892-2897.
- 18. Bronfman, F. C., A. Alvarez, C. Morgan, N. C. Inestrosa. Laminin Blocks the Assembly of Wild-Type Aβ and the Dutch Variant Peptide into Alzheimer’s Fibrils. – Amyloid, Vol. 5, 1998, No 1, pp. 16-23.
- 19. Nilsson, L. N. G., K. R. Bales, G. DiCarlo, M. N. Gordon, D. Morgan, S. M. Paul, H. Potter. α-1-Antichymotrypsin Promotes β-Sheet Amyloid Plaque Deposition in a Transgenic Mouse Model of Alzheimer’s Disease. – The Journal of Neuroscience, Vol. 21, 2001, No 5, pp. 1444-1451.
- 20. Hughes, S. R., O. Khorkova, S. Goyal, J. Knaeblein, J. Heroux, N. G. Riedel, S. Sahasrabudhe. 2-Macroglobulin Associates with -Amyloid Peptide and Prevents Fibril Formation. – Proceedings of the National Academy of Sciences, Vol. 95, 1998, No 6, pp. 3275-3280.
- 21. Thambisetty, M., A. Simmons, L. Velayudhan, A. Hye et al. Association of Plasma Clusterin Concentration with Severity, Pathology, and Progression in Alzheimer Disease. – Archives of General Psychiatry, Vol. 67, 2010, No 7, pp. 739-748.
- 22. Snow, A. D., R. Sekiguchi, D. Nochlin, P. Fraser, K. Kimata, A. Mizutani, M. Arai, W. A. Schreier, D. G. Morgan. An Important Role of Heparan Sulfate Proteoglycan (Perlecan) in a Model System for the Deposition and Persistence of Fibrillar Aβ-Amyloid in Rat Brain. – Neuron, Vol. 12, 1994, No 1, pp. 219-234.
- 23. Inestrosa, N. C., A. Alvarez, C. A. Pérez, R. D. Moreno, M. Vicente, C. Linker, O. I. Casanueva, C. Soto, J. Garrido. Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer’s Fibrils: Possible Role of the Peripheral Site of the Enzyme. – Neuron, Vol. 16, 1996, No 4, pp. 881-891.
- 24. Rees, T. Acetylcholinesterase Promotes Beta-Amyloid Plaques in Cerebral Cortex. – Neurobiology of Aging, Vol. 24, 2003, No 6, pp. 777-787.
- 25. Small, D. H., S. Michaelson, G. Sberna. Non-Classical Actions of Cholinesterases: Role in Cellular Differentiation, Tumorigenesis and Alzheimer’s Disease. – Neurochemistry International, Vol. 28, 1996, No 5-6, pp. 453-483.
- 26. Soreq, H., S. Seidman. Acetylcholinesterase – New Roles for an Old Actor. – Nature Reviews Neuroscience, Vol. 2, 2001, No 4, pp. 294-302.
- 27. Inestrosa, N. C., A. Perelman. Distribution and Anchoring of Molecular Forms of Acetylcholinesterase. – Trends in Pharmacological Sciences, Vol. 10, 1989, No 8, pp. 325-329.
- 28. Fernandez, H. L., R. D. Moreno, N. C. Inestrosa. Tetrameric (G4) Acetylcholinesterase: Structure, Localization, and Physiological Regulation. – Journal of Neurochemistry, Vol. 66, 2002, No 4, pp. 1335-1346.
- 29. Campos, E. O., A. Alvarez, N. C. Inestrosa. Brain Acetylcholinesterase Promotes Amyloid-β-Peptide Aggregation But Does Not Hydrolyze Amyloid Precursor Protein Peptides. – Neurochemical Research, Vol. 23, 1998, No 2, pp. 135-140.
- 30. Morán, M. A., E. J. Mufson, P. Gómez-Ramos. Colocalization of Cholinesterases with β-Amyloid Protein in Aged and Alzheimer’s Brains. – Acta Neuropathologica, Vol. 85, 1993, No 4, pp. 362-369.
- 31. Chacón, M. A., A. E. Reyes, N. C. Inestrosa. Acetylcholinesterase Induces Neuronal Cell Loss, Astrocyte Hypertrophy and Behavioral Deficits in Mammalian Hippocampus. – Journal of Neurochemistry, Vol. 87, 2003, No 1, pp. 195-204.
- 32. Inestrosa, N. C., A. Alvarez, J. Garrido, F. Calderón, F. C. Bronfman, F. Dajas, M. K. Gentry, B. P. Doctor. Acetylcholinesterase Promotes Alzheimer’s β-Amyloid Fibril Formation. – In: Alzheimer’s Disease: Biology, Diagnosis and Therapeutics. Vol. 1997. Chichester, Wiley, 1997, pp. 499-508.
- 33. Reyes, A. E., M. A. Chacón, M. C. Dinamarca, W. Cerpa, C. Morgan, N. C. Inestrosa. Acetylcholinesterase-Aβ Complexes are More Toxic Than Aβ Fibrils in Rat Hippocampus. – The American Journal of Pathology, Vol. 164, 2004, No 6, pp. 2163-2174.
- 34. Bolognesi, M. L., A. Minarini, M. Rosini, V. Tumiatti, C. Melchiorre. From Dual Binding Site Acetylcholinesterase Inhibitors to Multi-Target-Directed Ligands (MTDLs): A Step Forward in the Treatment of Alzheimers Disease. – Mini-Reviews in Medicinal Chemistry, Vol. 8, 2008, No 10, pp. 960-967.
- 35. De Ferrari, G. V., M. A. Canales, I. Shin, L. M. Weiner, I. Silman, N. C. Inestrosa. A Structural Motif of Acetylcholinesterase That Promotes Amyloid β-Peptide Fibril Formation. – Biochemistry, Vol. 40, 2001, No 35, pp. 10447-10457.
- 36. Hou, L.-N., J.-R. Xu, Q.-N. Zhao, X.-L. Gao, Y.-Y. Cui, J. Xu, H. Wang, H.-Z. Chen. A New Motif in the N-Terminal of Acetylcholinesterase Triggers Amyloid-β Aggregation and Deposition. – CNS Neuroscience & Therapeutics, Vol. 20, 2014, No 1, pp. 59-66.
- 37. Mishra, P., S. R. Ayyannan, G. Panda. Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design. – ChemMedChem, Vol. 10, 2015, No 9, pp. 1467-1474.
- 38. Lushchekina, S. V., E. D. Kots, D. A. Novichkova, K. A. Petrov, P. Masson. Role of Acetylcholinesterase in β-Amyloid Aggregation Studied by Accelerated Molecular Dynamics. – BioNanoScience, Vol. 7, 2017, No 2, pp. 396-402.
- 39. Cheung, J., M. J. Rudolph, F. Burshteyn, M. S. Cassidy, E. N. Gary, J. Love, M. C. Franklin, J. J. Height. Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands. – Journal of Medicinal Chemistry, Vol. 55, 2012, No 22, pp. 10282-10286.
- 40. Sticht, H., P. Bayer, D. Willbold, S. Dames, C. Hilbich, K. Beyreuther, R. W. Frank, P. Rosch. Structure of Amyloid A4-(1-40)-Peptide of Alzheimer’s Disease. – European Journal of Biochemistry, Vol. 233, 1995, No 1, pp. 293-298.
- 41. Lyskov, S., J. J. Gray. The RosettaDock Server for Local Protein-Protein Docking. – Nucleic Acids Research, Vol. 36 (Web Server issue), 2008, pp. W233-W238.
- 42. Wang, J., R. M. Wolf, J. W. Caldwell, P. A. Kollman, D. A. Case. Development and Testing of a General Amber Force Field. – Journal of Computational Chemistry, Vol. 25, 2004, No 9, pp. 1157-1174.
- 43. Adelman, S. A., J. D. Doll. Generalized Langevin Equation Approach for Atom/Solid Surface Scattering: Collinear Atom/Harmonic Chain Model. – The Journal of Chemical Physics, Vol. 61, 1974, No 10, pp. 4242-4245.
- 44. Berendsen, H. J. C., J. P. M. Postma, W. F. van Gunsteren, A. DiNola, J. R. Haak. Molecular Dynamics with Coupling to an External Bath. – The Journal of Chemical Physics, Vol. 81, 1984, No 8, pp. 3684-3690.
- 45. Maier, J. A., C. Martinez, K. Kasavajhala, L. Wickstrom, K. E. Hauser, C. Simmerling. Ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from Ff99SB. – Journal of Chemical Theory and Computation, Vol. 11, 2015, No 8, pp. 3696-3713.
- 46. Darden, T., D. York, L. Pedersen. Particle Mesh Ewald: An Nlog(N) Method for Ewald Sums in Large Systems. – The Journal of Chemical Physics, Vol. 98, 1993, No 12, pp. 10089-10092.
- 47. Ciccotti, G., J. P. Ryckaert. Molecular Dynamics Simulation of Rigid Molecules. – Computer Physics Reports, Vol. 4, 1986, No 6, pp. 346-392.
- 48. Roe, D. R., T. E. Cheatham. PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. – Journal of Chemical Theory And Computation, Vol. 9, 2013, No 7, pp. 3084-3095.
- 49. Weiser, J., P. S. Shenkin, W. C. Still. Approximate Atomic Surfaces From Linear Combinations of Pairwise Overlaps (LCPO). – Journal of Computational Chemistry, Vol. 20, 1999, No 2, pp. 217-230.
- 50. Case, D. A., I. Y. Ben-Shalom, S. R. Brozell, D. S. Cerutti et al. Amber 2018. Reference Manual. Vol. 2018. San Francisco, University of California.
- 51. Ivanov, S. M., I. Dimitrov, I. A. Doytchinova. Bridging Solvent Molecules Mediate RNase A – Ligand Binding. – PLoS ONE, Vol. 14, 2019, No 10, pp. 1-23.